Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

about

Drugs in development for toxoplasmosis: advances, challenges, and current status.An unexpected but underestimated case of disseminated toxoplasmosis.Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro Drug Resistance in

P2860

Q37613765-6133BE79-9CF0-419E-A8F7-E090A861BE40 Q48270822-CD79136E-59A2-4D54-97D8-97B76014676E Q56344152-12FC8E41-2F04-47D3-94D8-3E5C87DCFEF0 Q58699076-3E0FAB78-C975-421F-845E-C5BBA832D852

P2860

Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

Item

http://www.wikidata.org/entity/Q46831799

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Failure of primary atovaquone ...... ic cell transplant recipients.

@en

Failure of primary atovaquone ...... ic cell transplant recipients.

@nl

type

Item

label

Failure of primary atovaquone ...... ic cell transplant recipients.

@en

Failure of primary atovaquone ...... ic cell transplant recipients.

@nl

prefLabel

Failure of primary atovaquone ...... ic cell transplant recipients.

@en

Failure of primary atovaquone ...... ic cell transplant recipients.

@nl

P1476

Failure of primary atovaquone ...... ic cell transplant recipients.

@en

P2093

C A Gomez

http://www.w3.org/2001/XMLSchema#string

H Vogel

http://www.w3.org/2001/XMLSchema#string

J G Montoya

http://www.w3.org/2001/XMLSchema#string

K Gajurel

http://www.w3.org/2001/XMLSchema#string

R Dhakal

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.

Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature.

A typical bilateral Toxoplasma retinochoroiditis in a bone marrow transplant patient with negative serum titers.

Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.

Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.

Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.

Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.

P31

scholarly article

P356

10.1111/TID.12532

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27016655

http://www.w3.org/2001/XMLSchema#string

P921

toxoplasmosis

Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

about

P2860

P2860

Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921